b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="plospath" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2712764/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Novel Mechanistic Insights into Viral Modulation of Immune Receptor Signaling</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712764/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="PLoS Pathogens" /><meta name="citation_title" content="Novel Mechanistic Insights into Viral Modulation of Immune Receptor Signaling" /><meta name="citation_authors" content="Alexander B. Sigalov" /><meta name="citation_date" content="July 2009" /><meta name="citation_issue" content="7" /><meta name="citation_volume" content="5" /><meta name="citation_doi" content="10.1371/journal.ppat.1000404" /><meta name="citation_pmid" content="19649322" /><meta name="DC.Title" content="Novel Mechanistic Insights into Viral Modulation of Immune Receptor Signaling" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Public Library of Science" /><meta name="DC.Contributor" content="Alexander B. Sigalov" /><meta name="DC.Date" content="2009 Jul" /><meta name="DC.Identifier" content="10.1371/journal.ppat.1000404" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Novel Mechanistic Insights into Viral Modulation of Immune Receptor Signaling" /><meta property="og:type" content="article" /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712764/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-plospath.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2712764/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2712764/pdf/ppat.1000404.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1A8EFBE9A3C3210000000004090409.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/349/">PLoS Pathog</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/179617/">v.5(7); 2009 Jul</a></li><li class="accid">PMC2712764</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-plospath.gif" alt="Logo of plospath" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,438,55" alt="PLoS Pathogens" title="PLoS Pathogens" href="http://www.plospathogens.org/" ref="reftype=publisher&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="106,56,202,74" alt="Submit to PLoS" title="Submit to PLoS" href="http://www.plospathogens.org/static/checklist.action" ref="reftype=publisher&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="204,56,302,74" alt="Get E-mail Alerts" title="Get E-mail Alerts" href="http://journals.plos.org/alerts" ref="reftype=publisher&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="304,56,374,74" alt="Contact Us" title="Contact Us" href="http://www.plospathogens.org/static/contact.action" ref="reftype=publisher&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="440,0,500,55" alt="Public Library of Science (PLoS)" title="Public Library of Science (PLoS)" href="http://www.plos.org/" ref="reftype=publisher&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="0,56,104,74" alt="View this Article" title="View this Article" href="//dx.doi.org/10.1371/journal.ppat.1000404" ref="reftype=publisher&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText" target="pmc_ext" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">PLoS Pathog</span>. 2009 Jul; 5(7): e1000404. </span></div><div><span class="fm-vol-iss-date">Published online 2009 Jul 31. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1371%2Fjournal.ppat.1000404" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.ppat.1000404</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2712764</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/19649322">19649322</a></div></div></div></div><h1 class="content-title">Novel Mechanistic Insights into Viral Modulation of Immune Receptor Signaling</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Sigalov%20AB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19649322" class="affpopup" co-rid="_co_idm140479307287808" co-class="co-affbox">Alexander B. Sigalov</a><sup></sup><sup>\n&#x0002a;\n</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140479307287808"><h3 class="no_margin">Alexander B. Sigalov</h3><p>  Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America,   </p><div>Find articles by <a href="/pubmed/?term=Sigalov%20AB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19649322">Alexander B. Sigalov</a></div></div></div></div><div class="contrib-group half_rhythm fm-editor">Marianne Manchester, <span class="fm-role">Editor</span><sup></sup></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140479304168544_ai idm140479307287936_ai idm140479307284432_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140479304168544_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140479304168544_ai" style="display:none"><div class="fm-affl" lang="en" id="aff1">  Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America,   </div><div class="fm-affl" lang="en" id="edit1">The Scripps Research Institute, United States of America</div><div id="cor1">&#x0002a; E-mail: <a href="mailto:dev@null" data-email="ude.demssamu@volagiS.rednaxelA" class="oemail">ude.demssamu@volagiS.rednaxelA</a></div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140479304168544_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> Alexander B. Sigalov.</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2712764/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm140479300764496" class="tsec sec headless whole_rhythm"><p id="__p1" class="p p-first">To successfully infect, replicate, and persist in the host, viruses have evolved numerous strategies to take control of multiple cellular processes, including those that target transmembrane (TM) signal transduction mediated by immune receptors. Despite tremendous advancement in recent years, the exact molecular mechanisms underlying these critical points in viral pathogenesis remain unknown. In this Opinion, based on a novel model of immune signaling, the Signaling Chain HOmoOLigomerization (SCHOOL) model, I suggest specific mechanisms used by different viruses such as human immunodeficiency virus (HIV), cytomegalovirus (CMV), severe acute respiratory syndrome coronavirus (SARS-CoV), herpesvirus saimiri (HVS), human herpesvirus 6 (HHV-6), etc., to modulate the host immune response mediated by members of the family of multichain immune recognition receptors (MIRRs). I also demonstrate how the SCHOOL model, together with the lessons learned from viral pathogenesis, can be used practically for rational drug design and the development of new therapies for immune disorders.</p><p id="__p2">In MIRRs, the recognition domains and signaling sequences containing immunoreceptor tyrosine-based activation motifs (ITAMs) are located on separate subunits bound together by noncovalent TM interactions (<a href="/pmc/articles/PMC2712764/figure/ppat-1000404-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000404-g001" rid-ob="ob-ppat-1000404-g001" co-legend-rid="lgnd_ppat-1000404-g001"><span>Figure 1A</span></a>) <a href="#ppat.1000404-Biassoni1" rid="ppat.1000404-Biassoni1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923690">[1]</a>&#x02013;<a href="#ppat.1000404-Sigalov1" rid="ppat.1000404-Sigalov1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923691">[3]</a>. Based on a novel biophysical phenomenon, the homointeractions of intrinsically disordered proteins <a href="#ppat.1000404-Sigalov2" rid="ppat.1000404-Sigalov2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923630">[4]</a>,<a href="#ppat.1000404-Sigalov3" rid="ppat.1000404-Sigalov3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923681">[5]</a>, the SCHOOL model of MIRR signaling <a href="#ppat.1000404-Sigalov1" rid="ppat.1000404-Sigalov1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923680">[3]</a>, <a href="#ppat.1000404-Sigalov4" rid="ppat.1000404-Sigalov4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923658">[6]</a>&#x02013;<a href="#ppat.1000404-Sigalov6" rid="ppat.1000404-Sigalov6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923648">[8]</a> uncovers the molecular mechanisms by which clustering of the extracellular recognition domains leads to receptor triggering. The model suggests that MIRR engagement leads to receptor oligomerization coupled with a multi-step structural reorganization driven by the homooligomerization of signaling subunits (<a href="/pmc/articles/PMC2712764/figure/ppat-1000404-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000404-g001" rid-ob="ob-ppat-1000404-g001" co-legend-rid="lgnd_ppat-1000404-g001"><span>Figure 1B</span></a>). Importantly, this model is based on specific protein&#x02013;protein interactions&#x02014;biochemical processes that can be influenced and controlled, providing a promising drug design approach <a href="#ppat.1000404-Loregian1" rid="ppat.1000404-Loregian1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923646">[9]</a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="ppat-1000404-g001" co-legend-rid="lgnd_ppat-1000404-g001"><a href="/pmc/articles/PMC2712764/figure/ppat-1000404-g001/" target="figure" rid-figpopup="ppat-1000404-g001" rid-ob="ob-ppat-1000404-g001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140479304653936" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2712764_ppat.1000404.g001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is ppat.1000404.g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2712764/bin/ppat.1000404.g001.jpg" /></a></div><div id="largeobj_idm140479304653936" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2712764/figure/ppat-1000404-g001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_ppat-1000404-g001"><div><a class="figpopup" href="/pmc/articles/PMC2712764/figure/ppat-1000404-g001/" target="figure" rid-figpopup="ppat-1000404-g001" rid-ob="ob-ppat-1000404-g001">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Novel model of immune signaling reveals a new target and tools for immunomodulatory intervention.</strong><p id="__p3">(A) Multichain immune recognition receptor (MIRR) assembly. Binding and signaling subunits are shown in red and green, respectively. ITAMs are shown as orange rectangles. Transmembrane interactions between MIRR ligand-binding and signaling components (shown by solid arrow) play a key role in receptor assembly and integrity on resting cells. (B) The signaling chain homooligomerization (SCHOOL) model, which proposes that the homooligomerization of signaling subunits plays a central role in triggering MIRRs. Small solid black arrows indicate specific intersubunit hetero- and homointeractions between transmembrane and cytoplasmic domains, respectively. Circular arrow indicates ligand-induced receptor reorientation. All interchain interactions in a dimeric intermediate are shown by dotted black arrows reflecting their transition state. Phosphate groups are shown as dark circles. (C) Molecular mechanisms underlying proposed immunomodulatory intervention by transmembrane-targeted agents. Specific blockade of transmembrane interactions between MIRR recognition and signaling subunits results in &#x0201c;predissociation&#x0201d; of the receptor complex, thus preventing formation of signaling oligomers and inhibiting ligand-dependent immune cell activation. In contrast, stimulation of these predissociated MIRRs with cross-linking antibodies to signaling subunits should still lead to receptor triggering and cell activation (not shown).</p></div></div></div><p id="__p4">Within the model, specific blockade or disruption of TM interactions causes a physical and functional disconnection of the MIRR subunits (<a href="/pmc/articles/PMC2712764/figure/ppat-1000404-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000404-g001" rid-ob="ob-ppat-1000404-g001" co-legend-rid="lgnd_ppat-1000404-g001"><span>Figure 1C</span></a>) <a href="#ppat.1000404-Sigalov4" rid="ppat.1000404-Sigalov4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923639">[6]</a>,<a href="#ppat.1000404-Sigalov5" rid="ppat.1000404-Sigalov5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923696">[7]</a>,<a href="#ppat.1000404-Sigalov7" rid="ppat.1000404-Sigalov7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923707">[10]</a>,<a href="#ppat.1000404-Sigalov8" rid="ppat.1000404-Sigalov8" class=" bibr popnode">[11]</a>. Antigen stimulation of these &#x0201c;predissociated&#x0201d; receptors leads to reorientation and clustering of the recognition but not signaling subunits. As a result, signaling oligomers are not formed, ITAM Tyr residues do not become phosphorylated, and the signaling cascade is not initiated (<a href="/pmc/articles/PMC2712764/figure/ppat-1000404-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000404-g001" rid-ob="ob-ppat-1000404-g001" co-legend-rid="lgnd_ppat-1000404-g001"><span>Figure 1C</span></a>). In contrast, this &#x0201c;predissociation&#x0201d; does not prevent the formation of signaling oligomers when signaling subunits are clustered by specific antibodies that trigger cell activation (not illustrated).</p><p id="__p5">Predicted and molecularly explained by the SCHOOL model <a href="#ppat.1000404-Sigalov5" rid="ppat.1000404-Sigalov5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923652">[7]</a>, <a href="#ppat.1000404-Sigalov7" rid="ppat.1000404-Sigalov7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923675">[10]</a>&#x02013;<a href="#ppat.1000404-Kim1" rid="ppat.1000404-Kim1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848522811">[13]</a>, manipulation of MIRR signaling is performed by numerous unrelated viruses throughout their life cycle. In this context, the ability viruses have developed over centuries of evolution <a href="#ppat.1000404-Kim1" rid="ppat.1000404-Kim1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848522808">[13]</a>,<a href="#ppat.1000404-Jerome1" rid="ppat.1000404-Jerome1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923679">[14]</a> to modulate T cell receptor (TCR) signaling plays a crucial role in viral pathogenesis. For T lymphotropic viruses, the virus may inhibit TCR signaling to disarm the receptor and successfully enter the cell <a href="#ppat.1000404-Sigalov5" rid="ppat.1000404-Sigalov5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923671">[7]</a>,<a href="#ppat.1000404-Sigalov7" rid="ppat.1000404-Sigalov7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923659">[10]</a>,<a href="#ppat.1000404-Sigalov8" rid="ppat.1000404-Sigalov8" class=" bibr popnode">[11]</a>,<a href="#ppat.1000404-Kim1" rid="ppat.1000404-Kim1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848522812">[13]</a>,<a href="#ppat.1000404-Jerome1" rid="ppat.1000404-Jerome1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923656">[14]</a>. A similar strategy can be used by the virus to persist in the cell until it reactivates and produces infectious particles. For other viruses, modulation of TCR signaling can be used to inhibit the T cell response to infected cells <a href="#ppat.1000404-Sigalov5" rid="ppat.1000404-Sigalov5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923649">[7]</a>,<a href="#ppat.1000404-Sigalov8" rid="ppat.1000404-Sigalov8" class=" bibr popnode">[11]</a>,<a href="#ppat.1000404-Kim1" rid="ppat.1000404-Kim1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848522809">[13]</a>,<a href="#ppat.1000404-Jerome1" rid="ppat.1000404-Jerome1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923687">[14]</a>. Structurally, TCR is a member of the MIRR family and has the &#x003b1; and &#x003b2; antigen-binding subunits that are bound by electrostatic TM interactions with three signaling homo- and heterodimers: &#x003b6;&#x003b6;, CD3&#x003b5;&#x003b4;, and CD3&#x003b5;&#x003b3; (<a href="/pmc/articles/PMC2712764/figure/ppat-1000404-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000404-g002" rid-ob="ob-ppat-1000404-g002" co-legend-rid="lgnd_ppat-1000404-g002"><span>Figure 2A</span></a>) <a href="#ppat.1000404-Manolios1" rid="ppat.1000404-Manolios1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923688">[2]</a>,<a href="#ppat.1000404-Call1" rid="ppat.1000404-Call1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923662">[15]</a>. As suggested by the SCHOOL model <a href="#ppat.1000404-Sigalov5" rid="ppat.1000404-Sigalov5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923672">[7]</a>,<a href="#ppat.1000404-Sigalov7" rid="ppat.1000404-Sigalov7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923683">[10]</a>,<a href="#ppat.1000404-Sigalov8" rid="ppat.1000404-Sigalov8" class=" bibr popnode">[11]</a>,<a href="#ppat.1000404-Kim1" rid="ppat.1000404-Kim1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848522810">[13]</a>, these interactions are not only promising therapeutic targets, but also represent an important point of viral attack.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="ppat-1000404-g002" co-legend-rid="lgnd_ppat-1000404-g002"><a href="/pmc/articles/PMC2712764/figure/ppat-1000404-g002/" target="figure" rid-figpopup="ppat-1000404-g002" rid-ob="ob-ppat-1000404-g002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140479307756272" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2712764_ppat.1000404.g002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is ppat.1000404.g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2712764/bin/ppat.1000404.g002.jpg" /></a></div><div id="largeobj_idm140479307756272" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2712764/figure/ppat-1000404-g002/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_ppat-1000404-g002"><div><a class="figpopup" href="/pmc/articles/PMC2712764/figure/ppat-1000404-g002/" target="figure" rid-figpopup="ppat-1000404-g002" rid-ob="ob-ppat-1000404-g002">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Molecular mechanisms suggested by the SCHOOL model to be used by diverse viruses to modulate TCR signaling.</strong><p id="__p6">(A) TCR assembly. The &#x003b1; and &#x003b2; binding subunits are shown in red. The CD3&#x003b5;, CD3&#x003b4;, CD3&#x003b3;, and &#x003b6; signaling subunits are shown in green. ITAMs are shown as orange rectangles. Within the SCHOOL model, transmembrane-targeted agents such as TCR core peptide (CP) or HIV gp41 fusion peptide (FP) disrupt the transmembrane electrostatic interactions between the ligand-binding TCR&#x003b1; chain and CD3&#x003b4;&#x003b5; and &#x003b6;&#x003b6; by competing with the TCR&#x003b1; chain for binding to CD3&#x003b4;&#x003b5; and &#x003b6;&#x003b6; (B). This results in functional disconnection of the relevant signaling subunits ([C], shown as a simplified axial view) and prevents formation of signaling oligomers upon antigen but not antibody stimulation, thus inhibiting antigen-mediated but not anti-CD3-mediated TCR triggering and cell activation (D). Primary sequence analysis of proven and predicted immunomodulatory sequences of viral fusion protein regions and other domains shows a similarity in the charge distribution pattern with two essential positively charged residues (shown in blue) spaced apart by three to four or seven to eight amino acids (E), suggesting a similarity of mechanisms used by diverse viruses in their pathogenesis to modulate the host immune response. Note: Although the three-dimensional structures of the analyzed sequences within the cell membrane are not known, it might be assumed that these sequences may adopt a helical conformation upon membrane binding. Thus, helical wheel projections are used for illustrative purposes only; the suggested mode of action does not depend on a particular secondary structure of the sequences. Abbreviations: CKS-17, a synthetic retroviral envelope heptadecapeptide; Fr-MLV, Friend murine leukemia virus; gp, glycoprotein; HHV-6 U24, human herpesvirus 6 U24 protein; HTLV-1, human T lymphotropic virus type 1; HVA, herpesvirus ateles; HVS, herpesvirus saimiri; ITAM, immunoreceptor tyrosine-based activation motif; LASV, Lassa virus; LCMV, lymphocytic choriomeningitis virus; MARV, Marburg virus; MOPV, Mopeia virus; SARS-CoV, severe acute respiratory syndrome coronavirus; SEBOV, Sudan Ebola virus; TACV, Tacaribe virus; Tip, tyrosine kinase interacting protein; Tio, two-in-one protein; TMD, transmembrane domain; ZEBOV, Zaire Ebola virus.</p></div></div></div><p id="__p7">TM peptides capable of inhibiting TCR-mediated cell activation were first reported in 1997 <a href="#ppat.1000404-Manolios2" rid="ppat.1000404-Manolios2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923695">[16]</a>. The vast majority of findings were reported for the TCR core peptide (CP), a synthetic peptide corresponding to the sequence of the TCR&#x003b1; TM domain (TMD) and known to interact with the TMDs of CD3&#x003b4;&#x003b5; and &#x003b6; <a href="#ppat.1000404-Manolios1" rid="ppat.1000404-Manolios1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923677">[2]</a>,<a href="#ppat.1000404-Call1" rid="ppat.1000404-Call1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923667">[15]</a>. Interestingly, T cell activation via anti-CD3 antibodies is not affected by this peptide (<a href="/pmc/articles/PMC2712764/table/ppat-1000404-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="ppat-1000404-t001" rid-ob="ob-ppat-1000404-t001" co-legend-rid=""><span>Table 1</span></a>). As shown, TCR CP might be a proper treatment for human T cell-mediated dermatoses substituting for corticosteroids <a href="#ppat.1000404-Enk1" rid="ppat.1000404-Enk1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923638">[17]</a>,<a href="#ppat.1000404-Gollner1" rid="ppat.1000404-Gollner1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923665">[18]</a>. However, despite extensive studies <a href="#ppat.1000404-Manolios1" rid="ppat.1000404-Manolios1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923689">[2]</a>, <a href="#ppat.1000404-Enk1" rid="ppat.1000404-Enk1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923647">[17]</a>&#x02013;<a href="#ppat.1000404-Ali2" rid="ppat.1000404-Ali2" class=" bibr popnode">[28]</a>, the mode of action of this clinically relevant peptide was not explained until 2004 when the SCHOOL model was first introduced <a href="#ppat.1000404-Sigalov4" rid="ppat.1000404-Sigalov4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923640">[6]</a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="ppat-1000404-t001"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Similarities in Characteristics and Immunomodulatory Activities of the T Cell Receptor Core Peptide and HIV-1 gp41 Fusion Peptide.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140479304039216" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1">Characteristics/Activation Model</td><td align="left" rowspan="1" colspan="1">CP <a href="#ppat.1000404-Enk1" rid="ppat.1000404-Enk1" class=" bibr popnode">[17]</a>, <a href="#ppat.1000404-Wang1" rid="ppat.1000404-Wang1" class=" bibr popnode">[24]</a>&#x02013;<a href="#ppat.1000404-Amon2" rid="ppat.1000404-Amon2" class=" bibr popnode">[26]</a>\n</td><td align="left" rowspan="1" colspan="1">FP <a href="#ppat.1000404-Quintana1" rid="ppat.1000404-Quintana1" class=" bibr popnode">[29]</a>\n</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Colocalization with TCR</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td></tr><tr><td align="left" rowspan="1" colspan="1">Coprecipitation with TCR</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td></tr><tr><td align="left" rowspan="1" colspan="1">Immunosuppressive activity in vivo</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td></tr><tr><td align="left" rowspan="1" colspan="1">Inhibition of in vitro activation:</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Antigen</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td></tr><tr><td align="left" rowspan="1" colspan="1">Anti-TCR&#x003b2; antibody</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" rowspan="1" colspan="1">Anti-CD3 antibody</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">PMA/ionomycin</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td></tr></tbody></table></div><div id="largeobj_idm140479304039216" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2712764/table/ppat-1000404-t001/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="nt101"><p id="__p8" class="p p-first-last">TCR, T cell receptor; CP, core peptide; FP, fusion peptide; ND, not determined; PMA, phorbol 12-myristate 13-acetate.</p></div></div></div><p id="__p9">Recently, inhibition of T cell activation has been reported for the fusion peptide (FP) found in the N terminus of the HIV envelope glycoprotein 41 (gp41) <a href="#ppat.1000404-Quintana1" rid="ppat.1000404-Quintana1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923678">[29]</a>,<a href="#ppat.1000404-Bloch1" rid="ppat.1000404-Bloch1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923685">[30]</a>. These data are the first to demonstrate that not only does FP function to fuse the virion with the host cell membrane <a href="#ppat.1000404-Bosch1" rid="ppat.1000404-Bosch1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923670">[31]</a>,<a href="#ppat.1000404-Gallaher1" rid="ppat.1000404-Gallaher1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923676">[32]</a>, but it also has immunomodulatory activity. The peptide inhibits antigen- but not anti-CD3-stimulated T cell activation in vitro and has immunosuppressive activity in mice <a href="#ppat.1000404-Quintana1" rid="ppat.1000404-Quintana1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923651">[29]</a> (<a href="/pmc/articles/PMC2712764/table/ppat-1000404-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="ppat-1000404-t001" rid-ob="ob-ppat-1000404-t001" co-legend-rid=""><span>Table 1</span></a>). Similar to TCR CP <a href="#ppat.1000404-Gollner1" rid="ppat.1000404-Gollner1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923692">[18]</a>,<a href="#ppat.1000404-Kurosaka1" rid="ppat.1000404-Kurosaka1" class=" bibr popnode">[20]</a>,<a href="#ppat.1000404-Manolios3" rid="ppat.1000404-Manolios3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923642">[22]</a>,<a href="#ppat.1000404-Manolios4" rid="ppat.1000404-Manolios4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923661">[23]</a>, HIV FP has been suggested for the treatment of T cell-mediated pathologies <a href="#ppat.1000404-Quintana1" rid="ppat.1000404-Quintana1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923645">[29]</a>. However, the mode of action of this peptide remained unexplained until 2006 when the SCHOOL model was first applied to this area <a href="#ppat.1000404-Sigalov5" rid="ppat.1000404-Sigalov5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923693">[7]</a>.</p><p id="__p10">Considering the similarity between FP and CP in patterns of immunomodulatory activity (<a href="/pmc/articles/PMC2712764/table/ppat-1000404-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="ppat-1000404-t001" rid-ob="ob-ppat-1000404-t001" co-legend-rid=""><span>Table 1</span></a>) and in their having two electropositive residues in their primary sequences, the SCHOOL model reasonably suggests a similar mode of action for these peptides (<a href="/pmc/articles/PMC2712764/figure/ppat-1000404-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000404-g002" rid-ob="ob-ppat-1000404-g002" co-legend-rid="lgnd_ppat-1000404-g002"><span>Figure 2</span></a>) <a href="#ppat.1000404-Sigalov1" rid="ppat.1000404-Sigalov1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923686">[3]</a>, <a href="#ppat.1000404-Sigalov4" rid="ppat.1000404-Sigalov4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923694">[6]</a>, <a href="#ppat.1000404-Sigalov5" rid="ppat.1000404-Sigalov5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923636">[7]</a>, <a href="#ppat.1000404-Sigalov7" rid="ppat.1000404-Sigalov7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923654">[10]</a>&#x02013;<a href="#ppat.1000404-Sigalov9" rid="ppat.1000404-Sigalov9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923653">[12]</a>. Briefly, CP and FP compete with TCR&#x003b1; for binding to CD3&#x003b4;&#x003b5; and &#x003b6;&#x003b6;, resulting in functional disconnection of these subunits (<a href="/pmc/articles/PMC2712764/figure/ppat-1000404-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000404-g002" rid-ob="ob-ppat-1000404-g002" co-legend-rid="lgnd_ppat-1000404-g002"><span>Figure 2C</span></a>). This prevents formation of CD3&#x003b4;&#x003b5; and &#x003b6; signaling oligomers and thus inhibits T cell activation upon stimulation with antigen but not anti-CD3 antibodies (<a href="/pmc/articles/PMC2712764/figure/ppat-1000404-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000404-g002" rid-ob="ob-ppat-1000404-g002" co-legend-rid="lgnd_ppat-1000404-g002"><span>Figure 2D</span></a>), thereby suggesting a molecular explanation for the use of OKT3 antibodies in HIV therapy to augment immune activation <a href="#ppat.1000404-vanPraag1" rid="ppat.1000404-vanPraag1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923705">[33]</a>. Interestingly, the SCHOOL mechanism is the only one consistent with all of the experimental data on the immunomodulatory action of HIV FP and TCR CP reported so far <a href="#ppat.1000404-Manolios2" rid="ppat.1000404-Manolios2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923635">[16]</a>, <a href="#ppat.1000404-Kurosaka2" rid="ppat.1000404-Kurosaka2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923706">[21]</a>, <a href="#ppat.1000404-Wang1" rid="ppat.1000404-Wang1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923669">[24]</a>&#x02013;<a href="#ppat.1000404-Amon2" rid="ppat.1000404-Amon2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923643">[26]</a>, <a href="#ppat.1000404-Ali2" rid="ppat.1000404-Ali2" class=" bibr popnode">[28]</a>&#x02013;<a href="#ppat.1000404-Bloch1" rid="ppat.1000404-Bloch1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923664">[30]</a>.</p><p id="__p11">Charge distribution patterns for fusion protein regions are surprisingly conserved in many unrelated viruses and show similarities to those for TCR CP and HIV FP (<a href="/pmc/articles/PMC2712764/figure/ppat-1000404-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000404-g002" rid-ob="ob-ppat-1000404-g002" co-legend-rid="lgnd_ppat-1000404-g002"><span>Figure 2E</span></a>). Thus, it is highly probable that these proteins would also target the TCR TM interactions using the SCHOOL mechanism. Exploratory sequence investigation of FPs from SARS-CoV, Lassa virus (LASV), lymphocytic choriomeningitis virus (LCMV), Mopeia virus (MOPV), and Tacaribe virus (TACV) reveals a close similarity in the positioning of the electropositive residues (<a href="/pmc/articles/PMC2712764/figure/ppat-1000404-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000404-g002" rid-ob="ob-ppat-1000404-g002" co-legend-rid="lgnd_ppat-1000404-g002"><span>Figure 2E</span></a>). Intriguingly, analysis of other unrelated viruses has yielded similar correlations in primary structure and function. Earlier studies have reported an inhibitory effect on lymphocyte proliferation by CKS-17 peptide, a synthetic 17-mer peptide with sequence corresponding to a highly conserved region of TM proteins of human and animal retroviruses, including the TM protein gp21 of human T lymphotropic virus type 1 (HTLV-1) <a href="#ppat.1000404-Cianciolo1" rid="ppat.1000404-Cianciolo1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923666">[34]</a>&#x02013;<a href="#ppat.1000404-Ruegg2" rid="ppat.1000404-Ruegg2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923637">[36]</a>. Interestingly, peptides corresponding to regions of HIV TM protein gp41 homologous to the highly conserved and immunosuppressive sequence contained within the TM proteins p15E and gp21 of animal and human retroviruses, respectively, also have been reported to inhibit lymphoproliferation <a href="#ppat.1000404-Ruegg1" rid="ppat.1000404-Ruegg1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923650">[35]</a>,<a href="#ppat.1000404-Ruegg2" rid="ppat.1000404-Ruegg2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923663">[36]</a>. Recently, filoviral 17-mer peptides corresponding to a 17&#x02013;amino acid domain in filoviral glycoproteins that resembles an immunosuppressive motif in retroviral envelope proteins have been demonstrated to inhibit TCR-mediated cell activation <a href="#ppat.1000404-Yaddanapudi1" rid="ppat.1000404-Yaddanapudi1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923631">[37]</a>. In all peptides, a striking similarity is observed in the charge distribution patterns with the positioning of the essential positively charged residues almost identical to that for the HIV gp41 FP (<a href="/pmc/articles/PMC2712764/figure/ppat-1000404-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000404-g002" rid-ob="ob-ppat-1000404-g002" co-legend-rid="lgnd_ppat-1000404-g002"><span>Figure 2E</span></a>), suggesting again a similarity in their mode of action. This clearly demonstrates that different viruses have adopted similar mechanisms of specifically targeting TCR, disrupting receptor architecture, and suppressing the immune system. Importantly, by virtue of the acquired insight into this conserved structural motif, expanded predictions, hypotheses, and conclusions can be derived to being answering the question of whether shared TCR-targeted strategies represent a conserved function or a convergent tactic of divergent viruses.</p><p id="__p12">The generality of the SCHOOL model suggests that TM interactions of other MIRRs can also represent a point of viral attack. As reported <a href="#ppat.1000404-Arnon1" rid="ppat.1000404-Arnon1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923698">[38]</a>, the recognition of the human CMV tegument protein pp65 by NKp30, the natural killer (NK) cell-activating receptor, does not lead to NK cell activation but instead results in a general inhibition mediated by the dissociation of the NKp30-&#x003b6; complex and a loss in the ability of cells to kill virus-infected cells. Within the context of the SCHOOL model, pp65 may target the TM interactions between NKp30 and &#x003b6;, leading to functional disconnection of &#x003b6; in a manner similar to the action of TCR CP and HIV FP (<a href="/pmc/articles/PMC2712764/figure/ppat-1000404-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000404-g002" rid-ob="ob-ppat-1000404-g002" co-legend-rid="lgnd_ppat-1000404-g002"><span>Figure 2</span></a>).</p><p id="__p13">TM interactions can be targeted not only from outside but also from inside the cell. Recently, it has been shown that the HHV-6 U24 protein downregulates TCR surface expression and that U24-expressing T cells are resistant to activation by antigen-presenting cells <a href="#ppat.1000404-Sullivan1" rid="ppat.1000404-Sullivan1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923655">[39]</a>. By controlling lymphocyte activation that is often accompanied by herpesvirus reactivation, the virus might prevent its own reactivation and persist in a latent state, which is less prone to immune recognition <a href="#ppat.1000404-Sullivan1" rid="ppat.1000404-Sullivan1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923674">[39]</a>. In this context, U24 can serve to maintain equilibrium between the virus and its host by keeping HHV-6 titers low enough that they do not cause massive immune activation <a href="#ppat.1000404-Sullivan1" rid="ppat.1000404-Sullivan1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923704">[39]</a>. TCR downregulation activity also has been reported for the highly conserved membrane-proximal sequence of the tyrosine kinase-interacting protein (Tip) of HVS <a href="#ppat.1000404-Min1" rid="ppat.1000404-Min1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923632">[40]</a>,<a href="#ppat.1000404-Park1" rid="ppat.1000404-Park1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923701">[41]</a>. Notably, primary sequences of HHV-6 U24<sup>28&#x02013;60</sup> and HIV FP exhibit a similar pattern with two Arg residues spaced apart by eight amino acids (<a href="/pmc/articles/PMC2712764/figure/ppat-1000404-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000404-g002" rid-ob="ob-ppat-1000404-g002" co-legend-rid="lgnd_ppat-1000404-g002"><span>Figure 2E</span></a>). The positioning of the essential electropositive residues is remarkably conserved in HVS Tip<sup>213&#x02013;228</sup>, the relevant domain of the two-in-one (Tio) protein of herpesvirus ateles (HVA) and HTLV-1 gp21 (<a href="/pmc/articles/PMC2712764/figure/ppat-1000404-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000404-g002" rid-ob="ob-ppat-1000404-g002" co-legend-rid="lgnd_ppat-1000404-g002"><span>Figure 2E</span></a>). Thus, the SCHOOL mechanisms similar to those applied for TCR CP and HIV gp41 FP (<a href="/pmc/articles/PMC2712764/figure/ppat-1000404-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000404-g002" rid-ob="ob-ppat-1000404-g002" co-legend-rid="lgnd_ppat-1000404-g002"><span>Figure 2</span></a>) can be used by HHV-6 and other viruses in their arsenal of immune evasion tactics. Importantly, as predicted, the viral agents prevent only antigen- but not antibody-specific, T cell activation (<a href="/pmc/articles/PMC2712764/figure/ppat-1000404-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000404-g002" rid-ob="ob-ppat-1000404-g002" co-legend-rid="lgnd_ppat-1000404-g002"><span>Figure 2D</span></a>). Indeed, anti-CD3 antibodies activate HHV-6-infected T cells, resulting in a large increase of viral replication <a href="#ppat.1000404-Kikuta1" rid="ppat.1000404-Kikuta1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923673">[42]</a>,<a href="#ppat.1000404-Roffman1" rid="ppat.1000404-Roffman1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923697">[43]</a>. Interestingly, increase of viral replication induced by OKT3-mediated activation of HIV-infected T cells is currently used for purging of the latent HIV-1 reservoirs in vivo <a href="#ppat.1000404-vanPraag1" rid="ppat.1000404-vanPraag1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923684">[33]</a>, thus suggesting a potential generality of the SCHOOL mechanism-based antiviral approaches.</p><p id="__p14">There are several important lessons that we can learn from the molecular mechanisms of viral pathogenesis. First, using modern methodologies <a href="#ppat.1000404-Melnyk1" rid="ppat.1000404-Melnyk1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923644">[44]</a>&#x02013;<a href="#ppat.1000404-Killian1" rid="ppat.1000404-Killian1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923657">[51]</a>, it is possible to design and produce TM agents that are able to modulate the immune response as specifically and effectively as viruses do. Second, as predicted, TCR CP and many different immunomodulatory viral sequences affect similar TCR&#x02013;TM interactions, suggesting that general principles of designing TM peptides might be readily used at this stage <a href="#ppat.1000404-Yin1" rid="ppat.1000404-Yin1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923682">[47]</a>,<a href="#ppat.1000404-Wimley1" rid="ppat.1000404-Wimley1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923668">[48]</a>. Third, antibodies to MIRR signaling subunits can be used to modulate the affected immune cell response during viral infection. Fourth, considering our selective ability to functionally disconnect any particular TCR signaling subunits <a href="#ppat.1000404-Sigalov6" rid="ppat.1000404-Sigalov6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923703">[8]</a>,<a href="#ppat.1000404-Sigalov7" rid="ppat.1000404-Sigalov7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923700">[10]</a>,<a href="#ppat.1000404-Sigalov8" rid="ppat.1000404-Sigalov8" class=" bibr popnode">[11]</a>,<a href="#ppat.1000404-Collier1" rid="ppat.1000404-Collier1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633923633">[52]</a>, we can use the relevant peptides as a powerful tool to dissect fine mechanisms of viral pathogenesis. Finally, two unrelated viruses, HIV and human CMV, use a similar mode of action to modulate the host immune response mediated by two functionally different MIRRs, TCR and NKp30, thus suggesting that similar general mechanisms can be or are used by other viral and possibly non-viral pathogens.</p><p id="__p15" class="p">In conclusion, rather than targeting virus-specific proteins or processes, it would be advantageous to transfer therapeutic strategies that target redundant processes found among a number of viruses. In addition, as demonstrated by the similar function of natural HIV FP and synthetically derived clinically relevant TCR CP, viral immune evasion strategies can be transferred to therapeutic strategies that require similar functionalities. Viruses represent years of evolution and the efficiency and optimization that come along with it. Therefore, viral functions should not only be studied as foreign processes but as efficient strategies that we can use in our own attempts at immune evasion or immunomodulation.</p></div><div id="s2" class="tsec sec"><h2 class="head no_bottom_margin" id="s2title">Sequence Accession Numbers</h2><p id="__p16" class="p p-first-last">Accession numbers (UniProtKB/Swiss-Prot knowledgebase, <a href="http://www.expasy.org/sprot/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.expasy.org/sprot/</a>) for the viruses discussed in this Opinion are: CMV, <a id="__tag_821566234" class="tag_hotlink" href="/protein/P06725" ref="/protein/P06725"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"P06725","term_id":"130714","term_text":"P06725"}}</span>P06725</a>; Fr-MLV, <a id="__tag_821566225" class="tag_hotlink" href="/protein/P03390" ref="/protein/P03390"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"P03390","term_id":"119472","term_text":"P03390"}}</span>P03390</a>; HHV-6, <a id="__tag_821566228" class="tag_hotlink" href="/protein/Q69559" ref="/protein/Q69559"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"Q69559","term_id":"82013841","term_text":"Q69559"}}</span>Q69559</a>; HIV-1, <a id="__tag_821566227" class="tag_hotlink" href="/protein/P04578" ref="/protein/P04578"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"P04578","term_id":"6015102","term_text":"P04578"}}</span>P04578</a>; HTLV-1; <a id="__tag_821566233" class="tag_hotlink" href="/protein/P03381" ref="/protein/P03381"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"P03381","term_id":"119464","term_text":"P03381"}}</span>P03381</a>; HVA, <a id="__tag_821566237" class="tag_hotlink" href="/protein/Q9YJQ8" ref="/protein/Q9YJQ8"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"Q9YJQ8","term_id":"82007886","term_text":"Q9YJQ8"}}</span>Q9YJQ8</a>; HVS, <a id="__tag_821566239" class="tag_hotlink" href="/protein/P22575" ref="/protein/P22575"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"P22575","term_id":"140589","term_text":"P22575"}}</span>P22575</a>; LASV, <a id="__tag_821566232" class="tag_hotlink" href="/protein/P08669" ref="/protein/P08669"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"P08669","term_id":"138355","term_text":"P08669"}}</span>P08669</a>; LCMV, <a id="__tag_821566238" class="tag_hotlink" href="/protein/P07399" ref="/protein/P07399"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"P07399","term_id":"138357","term_text":"P07399"}}</span>P07399</a>; MARV, <a id="__tag_821566230" class="tag_hotlink" href="/protein/P35253" ref="/protein/P35253"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"P35253","term_id":"465412","term_text":"P35253"}}</span>P35253</a>; MOPV, <a id="__tag_821566229" class="tag_hotlink" href="/protein/P19240" ref="/protein/P19240"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"P19240","term_id":"138358","term_text":"P19240"}}</span>P19240</a>; SARS-CoV, <a id="__tag_821566235" class="tag_hotlink" href="/protein/P59594" ref="/protein/P59594"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"P59594","term_id":"30173397","term_text":"P59594"}}</span>P59594</a>; SEBOV, <a id="__tag_821566231" class="tag_hotlink" href="/protein/Q66814" ref="/protein/Q66814"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"Q66814","term_id":"8479515","term_text":"Q66814"}}</span>Q66814</a>; TACV, <a id="__tag_821566226" class="tag_hotlink" href="/protein/P18141" ref="/protein/P18141"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"P18141","term_id":"138360","term_text":"P18141"}}</span>P18141</a>; ZEBOV, <a id="__tag_821566236" class="tag_hotlink" href="/protein/Q05320" ref="/protein/Q05320"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"Q05320","term_id":"465411","term_text":"Q05320"}}</span>Q05320</a>.</p></div><div id="idm140479379375664" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140479379375664title">Acknowledgments</h2><div class="sec"><p id="__p17">I thank Walter M. Kim for his help with writing the manuscript.</p></div></div><div id="idm140479379375040" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140479379375040title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140479379374912"><p id="__p18" class="p p-first-last">The author has declared that no competing interests exist.</p></p><p class="fn sec" id="idm140479379374048"><p id="__p19" class="p p-first-last">This study was supported in part by the National Institutes of Health (<a href="http://www.nih.gov/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.nih.gov/</a>; project R21-AI074616). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></p></div></div><div id="idm140479379372160" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140479379372160title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Biassoni1">1. <span class="element-citation">Biassoni R, Cantoni C, Falco M, Pende D, Millo R, et al.  Human natural killer cell activating receptors. <span><span class="ref-journal">Mol Immunol. </span>2000;<span class="ref-vol">37</span>:1015\xe2\x80\x931024.</span> [<a href="/pubmed/11399319" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Immunol&amp;title=Human+natural+killer+cell+activating+receptors.&amp;author=R+Biassoni&amp;author=C+Cantoni&amp;author=M+Falco&amp;author=D+Pende&amp;author=R+Millo&amp;volume=37&amp;publication_year=2000&amp;pages=1015-1024&amp;pmid=11399319&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Manolios1">2. <span class="element-citation">Manolios N, Bonifacino JS, Klausner RD. Transmembrane helical interactions and the assembly of the T cell receptor complex. <span><span class="ref-journal">Science. </span>1990;<span class="ref-vol">249</span>:274\xe2\x80\x93277.</span> [<a href="/pubmed/2142801" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Transmembrane+helical+interactions+and+the+assembly+of+the+T+cell+receptor+complex.&amp;author=N+Manolios&amp;author=JS+Bonifacino&amp;author=RD+Klausner&amp;volume=249&amp;publication_year=1990&amp;pages=274-277&amp;pmid=2142801&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Sigalov1">3. <span class="element-citation">Sigalov A. Multi-chain immune recognition receptors: spatial organization and signal transduction. <span><span class="ref-journal">Semin Immunol. </span>2005;<span class="ref-vol">17</span>:51\xe2\x80\x9364.</span> [<a href="/pubmed/15582488" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Immunol&amp;title=Multi-chain+immune+recognition+receptors:+spatial+organization+and+signal+transduction.&amp;author=A+Sigalov&amp;volume=17&amp;publication_year=2005&amp;pages=51-64&amp;pmid=15582488&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Sigalov2">4. <span class="element-citation">Sigalov A, Aivazian D, Stern L. Homooligomerization of the cytoplasmic domain of the T cell receptor zeta chain and of other proteins containing the immunoreceptor tyrosine-based activation motif. <span><span class="ref-journal">Biochemistry. </span>2004;<span class="ref-vol">43</span>:2049\xe2\x80\x932061.</span> [<a href="/pubmed/14967045" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Homooligomerization+of+the+cytoplasmic+domain+of+the+T+cell+receptor+zeta+chain+and+of+other+proteins+containing+the+immunoreceptor+tyrosine-based+activation+motif.&amp;author=A+Sigalov&amp;author=D+Aivazian&amp;author=L+Stern&amp;volume=43&amp;publication_year=2004&amp;pages=2049-2061&amp;pmid=14967045&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Sigalov3">5. <span class="element-citation">Sigalov AB, Zhuravleva AV, Orekhov VY. Binding of intrinsically disordered proteins is not necessarily accompanied by a structural transition to a folded form. <span><span class="ref-journal">Biochimie. </span>2007;<span class="ref-vol">89</span>:419\xe2\x80\x93421.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2692994/">PMC free article</a>]</span> [<a href="/pubmed/17174464" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochimie&amp;title=Binding+of+intrinsically+disordered+proteins+is+not+necessarily+accompanied+by+a+structural+transition+to+a+folded+form.&amp;author=AB+Sigalov&amp;author=AV+Zhuravleva&amp;author=VY+Orekhov&amp;volume=89&amp;publication_year=2007&amp;pages=419-421&amp;pmid=17174464&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Sigalov4">6. <span class="element-citation">Sigalov AB. Multichain immune recognition receptor signaling: different players, same game? <span><span class="ref-journal">Trends Immunol. </span>2004;<span class="ref-vol">25</span>:583\xe2\x80\x93589.</span> [<a href="/pubmed/15489186" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Immunol&amp;title=Multichain+immune+recognition+receptor+signaling:+different+players,+same+game?&amp;author=AB+Sigalov&amp;volume=25&amp;publication_year=2004&amp;pages=583-589&amp;pmid=15489186&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Sigalov5">7. <span class="element-citation">Sigalov AB. Immune cell signaling: a novel mechanistic model reveals new therapeutic targets. <span><span class="ref-journal">Trends Pharmacol Sci. </span>2006;<span class="ref-vol">27</span>:518\xe2\x80\x93524.</span> [<a href="/pubmed/16908074" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Pharmacol+Sci&amp;title=Immune+cell+signaling:+a+novel+mechanistic+model+reveals+new+therapeutic+targets.&amp;author=AB+Sigalov&amp;volume=27&amp;publication_year=2006&amp;pages=518-524&amp;pmid=16908074&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Sigalov6">8. <span class="element-citation">Sigalov AB. Signaling chain homooligomerization (SCHOOL) model. <span><span class="ref-journal">Adv Exp Med Biol. </span>2008;<span class="ref-vol">640</span>:121\xe2\x80\x93163.</span> [<a href="/pubmed/19065790" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Exp+Med+Biol&amp;title=Signaling+chain+homooligomerization+(SCHOOL)+model.&amp;author=AB+Sigalov&amp;volume=640&amp;publication_year=2008&amp;pages=121-163&amp;pmid=19065790&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Loregian1">9. <span class="element-citation">Loregian A, Palu G. Disruption of protein-protein interactions: towards new targets for chemotherapy. <span><span class="ref-journal">J Cell Physiol. </span>2005;<span class="ref-vol">204</span>:750\xe2\x80\x93762.</span> [<a href="/pubmed/15880642" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Physiol&amp;title=Disruption+of+protein-protein+interactions:+towards+new+targets+for+chemotherapy.&amp;author=A+Loregian&amp;author=G+Palu&amp;volume=204&amp;publication_year=2005&amp;pages=750-762&amp;pmid=15880642&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Sigalov7">10. <span class="element-citation">Sigalov AB. Transmembrane interactions as immunotherapeutic targets: lessons from viral pathogenesis. <span><span class="ref-journal">Adv Exp Med Biol. </span>2007;<span class="ref-vol">601</span>:335\xe2\x80\x93344.</span> [<a href="/pubmed/17713022" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Exp+Med+Biol&amp;title=Transmembrane+interactions+as+immunotherapeutic+targets:+lessons+from+viral+pathogenesis.&amp;author=AB+Sigalov&amp;volume=601&amp;publication_year=2007&amp;pages=335-344&amp;pmid=17713022&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Sigalov8">11. <span class="element-citation">Sigalov AB.  SCHOOL model and new targeting strategies. In: Sigalov AB, editor. <span class="ref-journal">Multichain Immune Recognition Receptor Signaling: From Spatiotemporal Organization to Human Disease.</span> New York: Springer-Verlag New York Inc; 2008. pp. 268\xe2\x80\x93311. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Multichain+Immune+Recognition+Receptor+Signaling:+From+Spatiotemporal+Organization+to+Human+Disease&amp;author=AB+Sigalov&amp;publication_year=2008&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Sigalov9">12. <span class="element-citation">Sigalov AB. Interaction between HIV gp41 fusion peptide and T cell receptor: putting the puzzle pieces back together. <span><span class="ref-journal">Faseb J. </span>2007;<span class="ref-vol">21</span>:1633\xe2\x80\x931634; author reply 1635.</span> [<a href="/pubmed/17538030" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Faseb+J&amp;title=Interaction+between+HIV+gp41+fusion+peptide+and+T+cell+receptor:+putting+the+puzzle+pieces+back+together.&amp;author=AB+Sigalov&amp;volume=21&amp;publication_year=2007&amp;pages=1633-1634;+author+reply+1635&amp;pmid=17538030&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Kim1">13. <span class="element-citation">Kim WM, Sigalov AB. Viral pathogenesis, modulation of immune receptor signaling and treatment. <span><span class="ref-journal">Adv Exp Med Biol. </span>2008;<span class="ref-vol">640</span>:325\xe2\x80\x93349.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7122915/">PMC free article</a>]</span> [<a href="/pubmed/19065800" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Exp+Med+Biol&amp;title=Viral+pathogenesis,+modulation+of+immune+receptor+signaling+and+treatment.&amp;author=WM+Kim&amp;author=AB+Sigalov&amp;volume=640&amp;publication_year=2008&amp;pages=325-349&amp;pmid=19065800&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Jerome1">14. <span class="element-citation">Jerome KR. Viral modulation of T-cell receptor signaling. <span><span class="ref-journal">J Virol. </span>2008;<span class="ref-vol">82</span>:4194\xe2\x80\x934204.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2293063/">PMC free article</a>]</span> [<a href="/pubmed/18287237" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Viral+modulation+of+T-cell+receptor+signaling.&amp;author=KR+Jerome&amp;volume=82&amp;publication_year=2008&amp;pages=4194-4204&amp;pmid=18287237&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Call1">15. <span class="element-citation">Call ME, Pyrdol J, Wiedmann M, Wucherpfennig KW. The organizing principle in the formation of the T cell receptor-CD3 complex. <span><span class="ref-journal">Cell. </span>2002;<span class="ref-vol">111</span>:967\xe2\x80\x93979.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3420808/">PMC free article</a>]</span> [<a href="/pubmed/12507424" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=The+organizing+principle+in+the+formation+of+the+T+cell+receptor-CD3+complex.&amp;author=ME+Call&amp;author=J+Pyrdol&amp;author=M+Wiedmann&amp;author=KW+Wucherpfennig&amp;volume=111&amp;publication_year=2002&amp;pages=967-979&amp;pmid=12507424&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Manolios2">16. <span class="element-citation">Manolios N, Collier S, Taylor J, Pollard J, Harrison LC, et al.  T-cell antigen receptor transmembrane peptides modulate T-cell function and T cell-mediated disease. <span><span class="ref-journal">Nat Med. </span>1997;<span class="ref-vol">3</span>:84\xe2\x80\x9388.</span> [<a href="/pubmed/8986747" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=T-cell+antigen+receptor+transmembrane+peptides+modulate+T-cell+function+and+T+cell-mediated+disease.&amp;author=N+Manolios&amp;author=S+Collier&amp;author=J+Taylor&amp;author=J+Pollard&amp;author=LC+Harrison&amp;volume=3&amp;publication_year=1997&amp;pages=84-88&amp;pmid=8986747&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Enk1">17. <span class="element-citation">Enk AH, Knop J. T cell receptor mimic peptides and their potential application in T-cell-mediated disease. <span><span class="ref-journal">Int Arch Allergy Immunol. </span>2000;<span class="ref-vol">123</span>:275\xe2\x80\x93281.</span> [<a href="/pubmed/11146384" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+Arch+Allergy+Immunol&amp;title=T+cell+receptor+mimic+peptides+and+their+potential+application+in+T-cell-mediated+disease.&amp;author=AH+Enk&amp;author=J+Knop&amp;volume=123&amp;publication_year=2000&amp;pages=275-281&amp;pmid=11146384&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Gollner1">18. <span class="element-citation">Gollner GP, Muller G, Alt R, Knop J, Enk AH. Therapeutic application of T cell receptor mimic peptides or cDNA in the treatment of T cell-mediated skin diseases. <span><span class="ref-journal">Gene Ther. </span>2000;<span class="ref-vol">7</span>:1000\xe2\x80\x931004.</span> [<a href="/pubmed/10871747" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene+Ther&amp;title=Therapeutic+application+of+T+cell+receptor+mimic+peptides+or+cDNA+in+the+treatment+of+T+cell-mediated+skin+diseases.&amp;author=GP+Gollner&amp;author=G+Muller&amp;author=R+Alt&amp;author=J+Knop&amp;author=AH+Enk&amp;volume=7&amp;publication_year=2000&amp;pages=1000-1004&amp;pmid=10871747&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Amon1">19. <span class="element-citation">Amon MA, Ali M, Bender V, Hall K, Aguilar MI, et al.  Kinetic and conformational properties of a novel T-cell antigen receptor transmembrane peptide in model membranes. <span><span class="ref-journal">J Pept Sci. </span>2008;<span class="ref-vol">14</span>:714\xe2\x80\x93724.</span> [<a href="/pubmed/18240131" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pept+Sci&amp;title=Kinetic+and+conformational+properties+of+a+novel+T-cell+antigen+receptor+transmembrane+peptide+in+model+membranes.&amp;author=MA+Amon&amp;author=M+Ali&amp;author=V+Bender&amp;author=K+Hall&amp;author=MI+Aguilar&amp;volume=14&amp;publication_year=2008&amp;pages=714-724&amp;pmid=18240131&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Kurosaka1">20. <span class="element-citation">Kurosaka N, Ali M, Byth K, Manolios N. The mode of anti-arthritic peptide delivery impacts on the severity and outcome of adjuvant induced arthritis. <span><span class="ref-journal">APLAR J Rheumatol. </span>2007;<span class="ref-vol">10</span>:198\xe2\x80\x93203.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=APLAR+J+Rheumatol&amp;title=The+mode+of+anti-arthritic+peptide+delivery+impacts+on+the+severity+and+outcome+of+adjuvant+induced+arthritis.&amp;author=N+Kurosaka&amp;author=M+Ali&amp;author=K+Byth&amp;author=N+Manolios&amp;volume=10&amp;publication_year=2007&amp;pages=198-203&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Kurosaka2">21. <span class="element-citation">Kurosaka N, Bolte A, Ali M, Manolios N. T-cell antigen receptor assembly and cell surface expression is not affected by treatment with T-cell antigen receptor-alpha chain transmembrane Peptide. <span><span class="ref-journal">Protein Pept Lett. </span>2007;<span class="ref-vol">14</span>:299\xe2\x80\x93303.</span> [<a href="/pubmed/17346236" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Protein+Pept+Lett&amp;title=T-cell+antigen+receptor+assembly+and+cell+surface+expression+is+not+affected+by+treatment+with+T-cell+antigen+receptor-alpha+chain+transmembrane+Peptide.&amp;author=N+Kurosaka&amp;author=A+Bolte&amp;author=M+Ali&amp;author=N+Manolios&amp;volume=14&amp;publication_year=2007&amp;pages=299-303&amp;pmid=17346236&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Manolios3">22. <span class="element-citation">Manolios N, Ali M, Amon M, Bender V. Therapeutic application of transmembrane T and natural killer cell receptor peptides. <span><span class="ref-journal">Adv Exp Med Biol. </span>2008;<span class="ref-vol">640</span>:208\xe2\x80\x93219.</span> [<a href="/pubmed/19065794" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Exp+Med+Biol&amp;title=Therapeutic+application+of+transmembrane+T+and+natural+killer+cell+receptor+peptides.&amp;author=N+Manolios&amp;author=M+Ali&amp;author=M+Amon&amp;author=V+Bender&amp;volume=640&amp;publication_year=2008&amp;pages=208-219&amp;pmid=19065794&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Manolios4">23. <span class="element-citation">Manolios N, Huynh NT, Collier S. Peptides in the treatment of inflammatory skin disease. <span><span class="ref-journal">Australas J Dermatol. </span>2002;<span class="ref-vol">43</span>:226\xe2\x80\x93227.</span> [<a href="/pubmed/12121406" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Australas+J+Dermatol&amp;title=Peptides+in+the+treatment+of+inflammatory+skin+disease.&amp;author=N+Manolios&amp;author=NT+Huynh&amp;author=S+Collier&amp;volume=43&amp;publication_year=2002&amp;pages=226-227&amp;pmid=12121406&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Wang1">24. <span class="element-citation">Wang XM, Djordjevic JT, Bender V, Manolios N. T cell antigen receptor (TCR) transmembrane peptides colocalize with TCR, not lipid rafts, in surface membranes. <span><span class="ref-journal">Cell Immunol. </span>2002;<span class="ref-vol">215</span>:12\xe2\x80\x9319.</span> [<a href="/pubmed/12142032" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Immunol&amp;title=T+cell+antigen+receptor+(TCR)+transmembrane+peptides+colocalize+with+TCR,+not+lipid+rafts,+in+surface+membranes.&amp;author=XM+Wang&amp;author=JT+Djordjevic&amp;author=V+Bender&amp;author=N+Manolios&amp;volume=215&amp;publication_year=2002&amp;pages=12-19&amp;pmid=12142032&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Wang2">25. <span class="element-citation">Wang XM, Djordjevic JT, Kurosaka N, Schibeci S, Lee L, et al.  T-cell antigen receptor peptides inhibit signal transduction within the membrane bilayer. <span><span class="ref-journal">Clin Immunol. </span>2002;<span class="ref-vol">105</span>:199\xe2\x80\x93207.</span> [<a href="/pubmed/12482394" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Immunol&amp;title=T-cell+antigen+receptor+peptides+inhibit+signal+transduction+within+the+membrane+bilayer.&amp;author=XM+Wang&amp;author=JT+Djordjevic&amp;author=N+Kurosaka&amp;author=S+Schibeci&amp;author=L+Lee&amp;volume=105&amp;publication_year=2002&amp;pages=199-207&amp;pmid=12482394&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Amon2">26. <span class="element-citation">Amon MA, Ali M, Bender V, Chan YN, Toth I, et al.  Lipidation and glycosylation of a T cell antigen receptor (TCR) transmembrane hydrophobic peptide dramatically enhances in vitro and in vivo function. <span><span class="ref-journal">Biochim Biophys Acta </span>2006</span> [<a href="/pubmed/16782215" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim+Biophys+Acta&amp;title=Lipidation+and+glycosylation+of+a+T+cell+antigen+receptor+(TCR)+transmembrane+hydrophobic+peptide+dramatically+enhances+in+vitro+and+in+vivo+function.&amp;author=MA+Amon&amp;author=M+Ali&amp;author=V+Bender&amp;author=YN+Chan&amp;author=I+Toth&amp;publication_year=2006&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Ali1">27. <span class="element-citation">Ali M, Amon M, Bender V, Manolios N. Hydrophobic transmembrane-peptide lipid conjugations enhance membrane binding and functional activity in T-cells. <span><span class="ref-journal">Bioconjug Chem. </span>2005;<span class="ref-vol">16</span>:1556\xe2\x80\x931563.</span> [<a href="/pubmed/16287255" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioconjug+Chem&amp;title=Hydrophobic+transmembrane-peptide+lipid+conjugations+enhance+membrane+binding+and+functional+activity+in+T-cells.&amp;author=M+Ali&amp;author=M+Amon&amp;author=V+Bender&amp;author=N+Manolios&amp;volume=16&amp;publication_year=2005&amp;pages=1556-1563&amp;pmid=16287255&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Ali2">28. <span class="element-citation">Ali M, Salam NK, Amon M, Bender V, Hibbs DE, et al.  T-Cell Antigen Receptor-alpha Chain Transmembrane Peptides: Correlation between Structure and Function. <span><span class="ref-journal">Int J Pept Res Ther. </span>2006;<span class="ref-vol">12</span>:261\xe2\x80\x93267.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pept+Res+Ther&amp;title=T-Cell+Antigen+Receptor-alpha+Chain+Transmembrane+Peptides:+Correlation+between+Structure+and+Function.&amp;author=M+Ali&amp;author=NK+Salam&amp;author=M+Amon&amp;author=V+Bender&amp;author=DE+Hibbs&amp;volume=12&amp;publication_year=2006&amp;pages=261-267&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Quintana1">29. <span class="element-citation">Quintana FJ, Gerber D, Kent SC, Cohen IR, Shai Y. HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation. <span><span class="ref-journal">J Clin Invest. </span>2005;<span class="ref-vol">115</span>:2149\xe2\x80\x932158.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1172229/">PMC free article</a>]</span> [<a href="/pubmed/16007266" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=HIV-1+fusion+peptide+targets+the+TCR+and+inhibits+antigen-specific+T+cell+activation.&amp;author=FJ+Quintana&amp;author=D+Gerber&amp;author=SC+Kent&amp;author=IR+Cohen&amp;author=Y+Shai&amp;volume=115&amp;publication_year=2005&amp;pages=2149-2158&amp;pmid=16007266&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Bloch1">30. <span class="element-citation">Bloch I, Quintana FJ, Gerber D, Cohen T, Cohen IR, et al.  T-Cell inactivation and immunosuppressive activity induced by HIV gp41 via novel interacting motif. <span><span class="ref-journal">Faseb J. </span>2007;<span class="ref-vol">21</span>:393\xe2\x80\x93401.</span> [<a href="/pubmed/17185749" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Faseb+J&amp;title=T-Cell+inactivation+and+immunosuppressive+activity+induced+by+HIV+gp41+via+novel+interacting+motif.&amp;author=I+Bloch&amp;author=FJ+Quintana&amp;author=D+Gerber&amp;author=T+Cohen&amp;author=IR+Cohen&amp;volume=21&amp;publication_year=2007&amp;pages=393-401&amp;pmid=17185749&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Bosch1">31. <span class="element-citation">Bosch ML, Earl PL, Fargnoli K, Picciafuoco S, Giombini F, et al.  Identification of the fusion peptide of primate immunodeficiency viruses. <span><span class="ref-journal">Science. </span>1989;<span class="ref-vol">244</span>:694\xe2\x80\x93697.</span> [<a href="/pubmed/2541505" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Identification+of+the+fusion+peptide+of+primate+immunodeficiency+viruses.&amp;author=ML+Bosch&amp;author=PL+Earl&amp;author=K+Fargnoli&amp;author=S+Picciafuoco&amp;author=F+Giombini&amp;volume=244&amp;publication_year=1989&amp;pages=694-697&amp;pmid=2541505&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Gallaher1">32. <span class="element-citation">Gallaher WR. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. <span><span class="ref-journal">Cell. </span>1987;<span class="ref-vol">50</span>:327\xe2\x80\x93328.</span> [<a href="/pubmed/3496970" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Detection+of+a+fusion+peptide+sequence+in+the+transmembrane+protein+of+human+immunodeficiency+virus.&amp;author=WR+Gallaher&amp;volume=50&amp;publication_year=1987&amp;pages=327-328&amp;pmid=3496970&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-vanPraag1">33. <span class="element-citation">van Praag RM, Prins JM, Roos MT, Schellekens PT, Ten Berge IJ, et al.  OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4&#x0002b; T cell depletion. <span><span class="ref-journal">J Clin Immunol. </span>2001;<span class="ref-vol">21</span>:218\xe2\x80\x93226.</span> [<a href="/pubmed/11403229" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Immunol&amp;title=OKT3+and+IL-2+treatment+for+purging+of+the+latent+HIV-1+reservoir+in+vivo+results+in+selective+long-lasting+CD4&#x0002b;+T+cell+depletion.&amp;author=RM+van+Praag&amp;author=JM+Prins&amp;author=MT+Roos&amp;author=PT+Schellekens&amp;author=IJ+Ten+Berge&amp;volume=21&amp;publication_year=2001&amp;pages=218-226&amp;pmid=11403229&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Cianciolo1">34. <span class="element-citation">Cianciolo GJ, Copeland TD, Oroszlan S, Snyderman R. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. <span><span class="ref-journal">Science. </span>1985;<span class="ref-vol">230</span>:453\xe2\x80\x93455.</span> [<a href="/pubmed/2996136" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Inhibition+of+lymphocyte+proliferation+by+a+synthetic+peptide+homologous+to+retroviral+envelope+proteins.&amp;author=GJ+Cianciolo&amp;author=TD+Copeland&amp;author=S+Oroszlan&amp;author=R+Snyderman&amp;volume=230&amp;publication_year=1985&amp;pages=453-455&amp;pmid=2996136&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Ruegg1">35. <span class="element-citation">Ruegg CL, Monell CR, Strand M. Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II. <span><span class="ref-journal">J Virol. </span>1989;<span class="ref-vol">63</span>:3250\xe2\x80\x933256.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC250895/">PMC free article</a>]</span> [<a href="/pubmed/2746730" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Identification,+using+synthetic+peptides,+of+the+minimum+amino+acid+sequence+from+the+retroviral+transmembrane+protein+p15E+required+for+inhibition+of+lymphoproliferation+and+its+similarity+to+gp21+of+human+T-lymphotropic+virus+types+I+and+II.&amp;author=CL+Ruegg&amp;author=CR+Monell&amp;author=M+Strand&amp;volume=63&amp;publication_year=1989&amp;pages=3250-3256&amp;pmid=2746730&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Ruegg2">36. <span class="element-citation">Ruegg CL, Monell CR, Strand M. Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1. <span><span class="ref-journal">J Virol. </span>1989;<span class="ref-vol">63</span>:3257\xe2\x80\x933260.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC250896/">PMC free article</a>]</span> [<a href="/pubmed/2526228" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Inhibition+of+lymphoproliferation+by+a+synthetic+peptide+with+sequence+identity+to+gp41+of+human+immunodeficiency+virus+type+1.&amp;author=CL+Ruegg&amp;author=CR+Monell&amp;author=M+Strand&amp;volume=63&amp;publication_year=1989&amp;pages=3257-3260&amp;pmid=2526228&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Yaddanapudi1">37. <span class="element-citation">Yaddanapudi K, Palacios G, Towner JS, Chen I, Sariol CA, et al.  Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses. <span><span class="ref-journal">Faseb J. </span>2006;<span class="ref-vol">20</span>:2519\xe2\x80\x932530.</span> [<a href="/pubmed/17023517" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Faseb+J&amp;title=Implication+of+a+retrovirus-like+glycoprotein+peptide+in+the+immunopathogenesis+of+Ebola+and+Marburg+viruses.&amp;author=K+Yaddanapudi&amp;author=G+Palacios&amp;author=JS+Towner&amp;author=I+Chen&amp;author=CA+Sariol&amp;volume=20&amp;publication_year=2006&amp;pages=2519-2530&amp;pmid=17023517&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Arnon1">38. <span class="element-citation">Arnon TI, Achdout H, Levi O, Markel G, Saleh N, et al.  Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. <span><span class="ref-journal">Nat Immunol. </span>2005;<span class="ref-vol">6</span>:515\xe2\x80\x93523.</span> [<a href="/pubmed/15821739" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Immunol&amp;title=Inhibition+of+the+NKp30+activating+receptor+by+pp65+of+human+cytomegalovirus.&amp;author=TI+Arnon&amp;author=H+Achdout&amp;author=O+Levi&amp;author=G+Markel&amp;author=N+Saleh&amp;volume=6&amp;publication_year=2005&amp;pages=515-523&amp;pmid=15821739&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Sullivan1">39. <span class="element-citation">Sullivan BM, Coscoy L. Downregulation of the T-cell receptor complex and impairment of T-cell activation by human herpesvirus 6 u24 protein. <span><span class="ref-journal">J Virol. </span>2008;<span class="ref-vol">82</span>:602\xe2\x80\x93608.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2224597/">PMC free article</a>]</span> [<a href="/pubmed/17977973" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Downregulation+of+the+T-cell+receptor+complex+and+impairment+of+T-cell+activation+by+human+herpesvirus+6+u24+protein.&amp;author=BM+Sullivan&amp;author=L+Coscoy&amp;volume=82&amp;publication_year=2008&amp;pages=602-608&amp;pmid=17977973&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Min1">40. <span class="element-citation">Min CK, Bang SY, Cho BA, Choi YH, Yang JS, et al.  Role of amphipathic helix of a herpesviral protein in membrane deformation and T cell receptor downregulation. <span><span class="ref-journal">PLoS Pathog. </span>2008;<span class="ref-vol">4</span>:e1000209.</span> doi: <a href="http://dx.doi.org/10.1371/journal.ppat.1000209" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">10.1371/journal.ppat.1000209</a>. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2581436/">PMC free article</a>]</span> [<a href="/pubmed/19023411" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Pathog&amp;title=Role+of+amphipathic+helix+of+a+herpesviral+protein+in+membrane+deformation+and+T+cell+receptor+downregulation.&amp;author=CK+Min&amp;author=SY+Bang&amp;author=BA+Cho&amp;author=YH+Choi&amp;author=JS+Yang&amp;volume=4&amp;publication_year=2008&amp;pages=e1000209&amp;pmid=19023411&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Park1">41. <span class="element-citation">Park J, Lee BS, Choi JK, Means RE, Choe J, et al.  Herpesviral protein targets a cellular WD repeat endosomal protein to downregulate T lymphocyte receptor expression. <span><span class="ref-journal">Immunity. </span>2002;<span class="ref-vol">17</span>:221\xe2\x80\x93233.</span> [<a href="/pubmed/12196293" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=Herpesviral+protein+targets+a+cellular+WD+repeat+endosomal+protein+to+downregulate+T+lymphocyte+receptor+expression.&amp;author=J+Park&amp;author=BS+Lee&amp;author=JK+Choi&amp;author=RE+Means&amp;author=J+Choe&amp;volume=17&amp;publication_year=2002&amp;pages=221-233&amp;pmid=12196293&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Kikuta1">42. <span class="element-citation">Kikuta H, Lu H, Tomizawa K, Matsumoto S. Enhancement of human herpesvirus 6 replication in adult human lymphocytes by monoclonal antibody to CD3. <span><span class="ref-journal">J Infect Dis. </span>1990;<span class="ref-vol">161</span>:1085\xe2\x80\x931087.</span> [<a href="/pubmed/2161036" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Enhancement+of+human+herpesvirus+6+replication+in+adult+human+lymphocytes+by+monoclonal+antibody+to+CD3.&amp;author=H+Kikuta&amp;author=H+Lu&amp;author=K+Tomizawa&amp;author=S+Matsumoto&amp;volume=161&amp;publication_year=1990&amp;pages=1085-1087&amp;pmid=2161036&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Roffman1">43. <span class="element-citation">Roffman E, Frenkel N. Replication of human herpesvirus-6 in thymocytes activated by anti-CD3 antibody. <span><span class="ref-journal">J Infect Dis. </span>1991;<span class="ref-vol">164</span>:617\xe2\x80\x93618.</span> [<a href="/pubmed/1651362" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Replication+of+human+herpesvirus-6+in+thymocytes+activated+by+anti-CD3+antibody.&amp;author=E+Roffman&amp;author=N+Frenkel&amp;volume=164&amp;publication_year=1991&amp;pages=617-618&amp;pmid=1651362&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Melnyk1">44. <span class="element-citation">Melnyk RA, Partridge AW, Yip J, Wu Y, Goto NK, et al.  Polar residue tagging of transmembrane peptides. <span><span class="ref-journal">Biopolymers. </span>2003;<span class="ref-vol">71</span>:675\xe2\x80\x93685.</span> [<a href="/pubmed/14991677" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biopolymers&amp;title=Polar+residue+tagging+of+transmembrane+peptides.&amp;author=RA+Melnyk&amp;author=AW+Partridge&amp;author=J+Yip&amp;author=Y+Wu&amp;author=NK+Goto&amp;volume=71&amp;publication_year=2003&amp;pages=675-685&amp;pmid=14991677&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Smith1">45. <span class="element-citation">Smith SO, Smith C, Shekar S, Peersen O, Ziliox M, et al.  Transmembrane interactions in the activation of the Neu receptor tyrosine kinase. <span><span class="ref-journal">Biochemistry. </span>2002;<span class="ref-vol">41</span>:9321\xe2\x80\x939332.</span> [<a href="/pubmed/12135353" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Transmembrane+interactions+in+the+activation+of+the+Neu+receptor+tyrosine+kinase.&amp;author=SO+Smith&amp;author=C+Smith&amp;author=S+Shekar&amp;author=O+Peersen&amp;author=M+Ziliox&amp;volume=41&amp;publication_year=2002&amp;pages=9321-9332&amp;pmid=12135353&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Cunningham1">46. <span class="element-citation">Cunningham F, Deber CM. Optimizing synthesis and expression of transmembrane peptides and proteins. <span><span class="ref-journal">Methods. </span>2007;<span class="ref-vol">41</span>:370\xe2\x80\x93380.</span> [<a href="/pubmed/17367709" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Methods&amp;title=Optimizing+synthesis+and+expression+of+transmembrane+peptides+and+proteins.&amp;author=F+Cunningham&amp;author=CM+Deber&amp;volume=41&amp;publication_year=2007&amp;pages=370-380&amp;pmid=17367709&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Yin1">47. <span class="element-citation">Yin H, Slusky JS, Berger BW, Walters RS, Vilaire G, et al.  Computational design of peptides that target transmembrane helices. <span><span class="ref-journal">Science. </span>2007;<span class="ref-vol">315</span>:1817\xe2\x80\x931822.</span> [<a href="/pubmed/17395823" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Computational+design+of+peptides+that+target+transmembrane+helices.&amp;author=H+Yin&amp;author=JS+Slusky&amp;author=BW+Berger&amp;author=RS+Walters&amp;author=G+Vilaire&amp;volume=315&amp;publication_year=2007&amp;pages=1817-1822&amp;pmid=17395823&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Wimley1">48. <span class="element-citation">Wimley WC, White SH. Designing transmembrane alpha-helices that insert spontaneously. <span><span class="ref-journal">Biochemistry. </span>2000;<span class="ref-vol">39</span>:4432\xe2\x80\x934442.</span> [<a href="/pubmed/10757993" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Designing+transmembrane+alpha-helices+that+insert+spontaneously.&amp;author=WC+Wimley&amp;author=SH+White&amp;volume=39&amp;publication_year=2000&amp;pages=4432-4442&amp;pmid=10757993&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Edwards1">49. <span class="element-citation">Edwards RJ, Moran N, Devocelle M, Kiernan A, Meade G, et al.  Bioinformatic discovery of novel bioactive peptides. <span><span class="ref-journal">Nat Chem Biol. </span>2007;<span class="ref-vol">3</span>:108\xe2\x80\x93112.</span> [<a href="/pubmed/17220901" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Chem+Biol&amp;title=Bioinformatic+discovery+of+novel+bioactive+peptides.&amp;author=RJ+Edwards&amp;author=N+Moran&amp;author=M+Devocelle&amp;author=A+Kiernan&amp;author=G+Meade&amp;volume=3&amp;publication_year=2007&amp;pages=108-112&amp;pmid=17220901&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Ashish1">50. <span class="element-citation">Ashish, Wimley WC. Visual detection of specific, native interactions between soluble and microbead-tethered alpha-helices from membrane proteins. <span><span class="ref-journal">Biochemistry. </span>2001;<span class="ref-vol">40</span>:13753\xe2\x80\x9313759.</span> [<a href="/pubmed/11705363" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Visual+detection+of+specific,+native+interactions+between+soluble+and+microbead-tethered+alpha-helices+from+membrane+proteins.&amp;author=+Ashish&amp;author=WC+Wimley&amp;volume=40&amp;publication_year=2001&amp;pages=13753-13759&amp;pmid=11705363&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Killian1">51. <span class="element-citation">Killian JA. Synthetic peptides as models for intrinsic membrane proteins. <span><span class="ref-journal">FEBS Lett. </span>2003;<span class="ref-vol">555</span>:134\xe2\x80\x93138.</span> [<a href="/pubmed/14630333" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;title=Synthetic+peptides+as+models+for+intrinsic+membrane+proteins.&amp;author=JA+Killian&amp;volume=555&amp;publication_year=2003&amp;pages=134-138&amp;pmid=14630333&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000404-Collier1">52. <span class="element-citation">Collier S, Bolte A, Manolios N. Discrepancy in CD3-transmembrane peptide activity between in vitro and in vivo T-cell inhibition. <span><span class="ref-journal">Scand J Immunol. </span>2006;<span class="ref-vol">64</span>:388\xe2\x80\x93391.</span> [<a href="/pubmed/16970679" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Scand+J+Immunol&amp;title=Discrepancy+in+CD3-transmembrane+peptide+activity+between+in+vitro+and+in+vivo+T-cell+inhibition.&amp;author=S+Collier&amp;author=A+Bolte&amp;author=N+Manolios&amp;volume=64&amp;publication_year=2006&amp;pages=388-391&amp;pmid=16970679&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2712764&amp;issue-id=179617&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">PLoS Pathogens</span> are provided here courtesy of <strong>Public Library of Science</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2712764/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2712764/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2712764/pdf/ppat.1000404.pdf">PDF (274K)</a></li> | <li><a href="#" data-citationid="PMC2712764" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2712764%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2712764%2F&amp;text=Novel%20Mechanistic%20Insights%20into%20Viral%20Modulation%20of%20Immune%20Receptor%20Signaling"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2712764%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="19649322" data-aiid="2712764" data-aid="2712764" data-iid="179617" data-domainid="349" data-domain="plospath" data-accid="PMC2712764" data-md5="5a9470e23c8b4e8dfd912af23f04acc5"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T20:19:39-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1A8EFBE9A3C3210000000004090409&amp;ncbi_session=8A1A8EFBE9A479B1_1033SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2712764%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=plospath&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2712764/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1A8EFBE9A479B1_1033SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'